BNET Industries
caliper life sciences inc. - All News and Analysis
Caliper Life Sciences, Inc. Q3 2008 Earnings Call Transcript
Question-and-Answer Session Operator Operator instructions And the first question comes from the line is Steven Crowley with Craig-Hallum Capital Group. Please proceed. Steven Crowley – Craig-Hallum Capital Group Good after noon gentlemen. Kevin Hrusovsky Hi, Steve. Steven Crowley – Craig-Hallum Capital Group First of all congratulations on bolstering the...
Caliper Life Sciences, Inc. Q2 2008 Earnings Call Transcript
Question-and-Answer Session Operator Operator instructions Our first question comes from the line of David Clair from Piper Jaffray. Please proceed. David Clair – Piper Jaffray Hey, guys, can you hear me? Kevin Hrusovsky Hi David. We can. Peter McAree Hi, David. David Clair...
Begins NANO-TECH Industry Specific Research on APPLIED FILMS CORPORATION (NASDAQ: AFCO) and CALIPER LIFE SCIENCES, INC.(NASDAQ: CALP) for Friday Dec 2, 2005.
M2 PRESSWIRE-5 December 2005-StockstoFollow.com: Begins NANO-TECH Industry Specific Research on APPLIED FILMS CORPORATION (NASDAQ: AFCO) and CALIPER LIFE SCIENCES, INC.(NASDAQ: CALP) for Friday Dec 2, 2005C1994-2005 M2 COMMUNICATIONS LTD RDATE:02122005 Sign-up for our FREE Stock Alerts at http://www.StockstoFollow.com ! ...
Additional Resources
Caliper Life Sciences to Present at J.P. Morgan 27th Annual Healthcare Conference
HOPKINTON, Mass., Dec. 23 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. today announced that President and CEO, Kevin Hrusovsky, will present at the J.P. Morgan 27th Annual Healthcare Conference in San Francisco, California, on January 15, 2009 at 12:00 p.m. PST. A live webcast of the presentation...
Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
NEW YORK, Dec. 17 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. today announced the appointment of Pamela R. Contag, Ph.D., to Delcath's Board of Directors. Dr. Contag is a proven corporate executive with extensive experience working with international and domestic investors. (LOGO: http://www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO ) ...
Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
- Completes Restructuring and Two Divestitures of Non-Core Product Lines - HOPKINTON, Mass., Nov. 10 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. today reported third quarter financial results for 2008 and the completion of two product line divestitures: the sale of its AutoTraceR product line to...
Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
- Sale Reinforces Strategic Focus and Enhances Cash Position - HOPKINTON, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. , a leading provider of tools and services for drug discovery and life sciences research, today announced that it has reached an agreement to sell its Pharmaceutical...
Caliper Life Sciences' Third Quarter 2008 Financial Results Conference Call Notice
MONDAY, November 10, 2008 5:00 p.m. EST HOPKINTON, Mass., Oct. 23 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. will conduct a conference call discussing the company's third quarter 2008 financial results at 5:00 p.m. EST on Monday, November 10. Kevin Hrusovsky, President and Chief Executive Officer and...
Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays
- PathHunter eXpress Kits Combined with LabChip Microfluidic Instruments Provide a Comprehensive, High Quality, Easy-to-Use GPCR Assay Solution - HOPKINTON, Mass. and FREMONT, Calif., Oct. 7 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. and DiscoveRx, today announced the commercial availability of PathHunterTM eXpress Beta-Arrestin kits for use...
Caliper Life Sciences is bundling DiscovRx's cell-based GPCR assays
* Caliper Life Sciences is bundling DiscovRx's cell-based GPCR assays with its LabChip platforms...
Carna Biosciences signed a collaborative agreement with Caliper Life Sciences in August
* Carna Biosciences signed a collaborative agreement with Caliper Life Sciences in August to supply a set of discrete protein kinases...
The bottom line
The Bottom LineData from recent industry financial reports. Dollar amounts inmillions.Company Period ...
Caliper Life Sciences gained limited access to certain optical imaging technologies
Caliper Life Sciences gained limited access to certain optical imaging technologies owned by biophotonics company Spectros...
Caliper Life Sciences
Caliper Life Sciences introduced the LabChip GX and GXII for automated 1-D electrophoretic separations, featuring the ability to analyze any single sample...
Caliper Life Sciences
Caliper Life Sciences will consolidate its West Coast operations, resulting in expected annual cost savings of $3.3 million. Thirteen positions will be eliminated...
Caliper Life Sciences
Caliper Life Sciences launched Bioware Ultra cell lines for in vivo imaging, enabling single-cell detection...
Caliper Life Sciences
Caliper Life Sciences appointed Peter F. McAree senior vice president and CFO in April. He was previously vice president of Finance...
Caliper Life Sciences
Caliper Life Sciences introduced the Zephyr Solid Phase Extraction Workstation at a price of $65,000...
Under an alliance with Horizon Discovery, Caliper Life Sciences' Caliper Discovery Alliances and Services added isogenic human cancer cell lines
Under an alliance with Horizon Discovery, Caliper Life Sciences' Caliper Discovery Alliances and Services added isogenic human cancer cell lines to its oncology cell proliferation panel...
Caliper Life Sciences
Caliper Life Sciences reduced the size of its Board from eight to seven members, following the expiration of Dr. Daniel Kisner's term...
Sort byClose
View by Content TypeClose
- Revenue (Fiscal Year) $140.7M
- Profit (Fiscal Year) ($24.0M)
- Incorporated: 1995
- CEO: Mr. E. Kevin Hrusovsky
Caliper Life Sciences sells products, services and integrated systems comprised of instruments, software and reagents to life sciences, biomedical and pharmaceutical researchers. Co.'s products and services are assembled from its portfolio of microfluidics, automation, liquid handling, and molecular imaging technologies. Co. also provides in-vitro and in-vivo products and services through its NovaScreen Biosciences Corp. and Xenogen Corp. subsidiaries. As of Dec 31 2006, Co. groups its key automation and liquid handling product offerings into two categories: drug discovery and life sciences research (drug discovery), and pharmaceutical development and manufacturing (drug development).
Competitors
Stock Quote
Board of Directors
Dr. David V. Milligan Ph.D. Vice-Chairman
Mr. Allan L. Comstock
Ms. Kathryn A. Tunstall
Mr. E. Kevin Hrusovsky
Mr. David W. Carter
Mr. Van Billet
Dr. Robert C. Bishop Ph.D.
NAICS Code
Analytical Laboratory Instrument Manufacturing: 334516
Industry Transcripts by Seeking Alpha
-
AngioDynamics Inc., F2Q09 (Qtr End 11/30/08) Earnings Call Transcript
on Jan 06, 2009about ANGO
-
Centene Corporation 2009 Financial Guidance Call Transcript
on Dec 19, 2008about CNC
-
Bio-Reference Laboratories, Inc. Q4FY08 Earnings Call Transcript
on Dec 18, 2008about BRLI
-
Magellan Health Services, Inc. 2009 Financial Guidance Call Transcript
on Dec 17, 2008about MGLN
-
The Cooper Companies, Inc. F4Q08 (Qtr End 10/31/08) Earnings Call Transcript
on Dec 09, 2008about COO